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1.1 PROBLEM STATEMENT 
 
The human body has remarkable regenerative and repair mechanisms, where 
regeneration of tissue and function are achievable in many parts of the body.1,2  
But for many centuries, physicians and scientists have attempted to repair or 
regenerate articular cartilage.  To this day, it is still widely accepted that 
ulcerated cartilage cannot be fully regenerated.  Despite advances in science and 
clinical therapies, full restoration of the biochemical composition, structural 
organization and mechanical properties of cartilage have not yet been achieved.3   
 
Articular cartilage is a very complex organ that is unique in its isolation from the 
body.  Due to the absence of vasculature, lymphatic vessels, and nerves, the 
repair mechanisms that are usually elicited after an injury do not occur.  Repair 
mechanisms are only activated when the subchondral bone is penetrated during 
an injury.  The repair tissue that forms is a type of fibrocartilage that is composed 
of collagen I and substitute proteoglycans.  This tissue does not have biochemical 
or mechanical properties comparable to native tissue, and will generally lead to 
degeneration of the repair tissue.    
 
The difficulty with regeneration of articular cartilage is due to a deficit of three 
key elements: 1) a large number of responsive cells able to repopulate the defect, 
2) growth factors and signaling molecules to promote new tissue formation, and 
3) an extracellular matrix or framework that fills the defect space and helps 
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organize the cells spatially.4  The clinical therapies used currently for articular 
cartilage defects do address some of these concerns, but not all three at once.  
Thus, fibrocartilage formation is still the standard result and in many cases 
treatment only temporarily alleviates the pain and/or problem.5 
 
The development of tissue engineering strategies has increased the potential to 
promote chondrogenesis in defects and enhance the quality of the repair tissue.  
Tissue engineering combines responsive cells with the appropriate growth 
factors and biomaterials matrices to address the three deficits together.  For 
cartilage repair and regeneration, a combination of these three elements and an 
understanding of the defect microenvironment will lead to the generation of 
more hyaline-like tissues.  Many scientists have investigated the formation of 
repair tissue stimulated by microenvironments that induce cellular condensation 
and chondrogenic differentiation.  Some factors that initiate chondrogenesis such 
as growth factor cocktail6,7 and high cellular density8,9 have been established.  
Other aspects that will make these tissue-engineered constructs feasible for use in 
clinical defects continue to be unresolved.  One such factor is the poor 
mechanical stability of the matrices currently being investigated for cartilage 
tissue engineering.10 Another factor that has not been examined readily is the 
physical properties of scaffolds that are used for cartilage tissue engineering and 
their impact on tissue regeneration. 
 
1.2 GENERAL STRATEGY 
 
Our approach to cartilage tissue engineering focuses on stimulating adult 
mesenchymal stem cells and chondrocytes to form new cartilage tissue within 
solid freeform (SFF) fabricated scaffolds.  SFF technology is a powerful scaffold 
fabrication method that allows users to define many scaffold properties, such as 
the external geometries, porosity, pore architecture, pore size, and scaffold 
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permeability.  Furthermore, the mechanical properties of the SFF scaffolds can 
also be controlled and adjusted to provide support to the developing tissue.  
Since many of these scaffold properties could not be manipulated or defined 
with the conventional scaffolds used in cartilage tissue engineering, the desired 
scaffold properties remain largely unknown.  The advantage of SFF is the ability 
to design scaffolds that can isolate these properties, so that we can begin to 
understand how the physical properties of scaffolds influence cartilage tissue 
formation.   
 
The work in this thesis examines chondroinductive and chondrochonductive 
microenvironments that induce cellular condensation and evaluate the ability of 
these microenvironments to stimulate chondrogenesis by BMSC and 
chondrocytes within SFF scaffolds.  First, chondroinductive hyaluronic acid 
(HyA) hydrogels that will serve as cell carriers for the SFF scaffolds are evaluated.  
The hydrogels increase cellular retention within the SFF scaffolds and HyA is an 
ubiquitous glycosaminoglycan that is present during mesenchymal condensation.  
It facilitates cellular migration, proliferation, and also aids in the formation of 
cellular aggregates.  HyA is also found in the extracellular matrix of cartilage, 
where it also serves a mechanical role, as the backbone of the proteoglycan 
network.  The second step evaluates the effect of two designed pore geometries, 
cubic and ellipsoid, on cartilage tissue formation.  Previous research has shown 
that high cellular density, spherical cell morphology, and lower permeabilities 
are required for chondrogenic differentiation.  The ellipsoid pore geometry 
mimics the shape of cellular condensations and increases cellular packing 
density, which will in turn increase chondrogenic differentiation.  The last part 
combines the hyaluronic acid hydrogels with designed pore geometries to assess 




The global hypothesis of this thesis is that the formation of high-density 
cellular condensations directed by biomolecules (hyaluronic acid) and 
designed scaffold architecture in the presence of chondroinductive growth 
factors will provide an environment that enhances chondrogenesis by bone 
marrow stromal cells (BMSC) and chondrocytes in SFF scaffolds.  
  
After a short introduction to the morphogenesis of cartilage and the properties of 
articular cartilage, Chapter 2 reviews the current treatment methods for cartilage 
defects, relevant studies in cartilage tissue engineering, and the motivations 
behind the work in this thesis.  Chapter 3 describes the assessment of hyaluronic 
acid hydrogels both in vitro and in vivo in SFF scaffolds.  In Chapter 4, the effect 
of SFF scaffold pore geometry on chondrogenesis is investigated.  The combined 
effects of HyA hydrogels and SFF scaffold pore geometry are detailed in Chapter 
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Articular cartilage is a complex organ that is unique in its isolation from the body 
due to the absence of vasculature, lymphatic vessels, and nerves.  In its isolation, 
the repair mechanisms of the body that are usually elicited after an injury do not 
occur.  A repair response is only generated when the underlying subchondral 
bone is penetrated.  The infiltrating blood brings mesenchymal stem cells and 
growth factors required for growth and regeneration.  It is through a 
combination of this response and the events of embryonic cartilage 
morphogenesis, that we model the research described in this thesis.  The 
objective is to create conducive microenvironments for chondrogenic 
differentiation by using biochemical and biomaterial scaffolds that influence 
cellular condensation.  Creating microenvironments that are present during limb 
morphogenesis will help us recreate a tissue construct that will be able to 
regenerate function and promote the growth of tissue that is similar to native 
tissue.  
 
The field of tissue engineering has opened up new possibilities for repair and 
regeneration of cartilage by combining responsive cells, biological factors, and 
scaffold matrices.1,2  By using these three key elements, scientists hope to recreate 
an environment that initiates morphogenesis or a regenerative response after 
injury.  For cartilage tissue engineering, this biomimetic approach can be 
recapitulated in the chondrogenic events of the embryo.  During embryonic pre-
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chondrogenesis, mesenchymal progenitor cells form cellular condensations, 
which become the template for cartilaginous and osseous formation.  Through a 
series of cell-cell, cell-matrix interactions and other signaling mechanisms, the 
cells within these condensations differentiate into chondrocytes.  Bone then 
replaces cartilage and in some areas, the cartilage becomes permanent.  
Understanding this process of chondrogenesis and endochondral ossification 
should elucidate fundamental factors that are required for chondrogenesis of 
hyaline-like repair tissue in adults.   
 
2.2    MORPHOGENESIS OF CARTILAGE 
 
The embryonic limb is considered the classic model for studying cartilage 
morphogenesis.  The formation of a skeletal element that will develop into a limb 
occurs in a four phase process: 1) migration of mesenchymal cells to the site of 
skeletogenesis, 2) the interaction of the mesenchymal cells with epithelium and 
epithelial basement membrane, 3) these interactions with epithelial cell products 
initiate cellular condensation and 4) overt differentiation of cells into 
chondroblasts or osteoblasts. 3  The first step of the process begins when 
undifferentiated mesenchymal cells start to produce an extracellular matrix that 
is rich in collagen I, hyaluronan, tenascin and fibronectin. 4  These proteins in the 
matrix aid in the migration of dispersed MSC population to a central location.   
 
The epithelial-mesenchyme interactions of the second phase localize the 
skeletogenic mesenchyme.  The interactions also provide signals to initiate 
condensation of the mesenchyme, permit differentiation of cartilage (or bone, 




Condensation is the earliest stage during organ formation when tissue-specific 
genes are upregulated.  It is a multistep process where initiation, establishment 
of boundary conditions, cell adhesion, proliferation, growth, and cessation of 
growth occur.  There are a few ways in which condensations may arise: 1) a 
difference between the cells within the condensation and the cells surrounding 
the condensation, 2) the cells within the aggregate may have increased 
proliferation, have shorter cell cycle times, or decreased cell death, 3) the cells are 
part of a larger dividing cell population or 4) the cells are migrating towards a 
center or do not move away from a center.  These cellular condensations lead to 
altered mitotic activity, changed cell density, and aggregation. The mesenchymal 
cells within these condensations have a round morphology, high nucleo-
cytoplasmic ratio, large nucleoli, poorly developed endoplasmic reticulum, and 
small mitochondria. (FIGURE 2.1)  The condensation is accompanied by an 
increase in gap junction formation and increased cell-to-cell communication.6 
 
In order for the cells to proceed into the differentiation, they must attain a critical 
size.  Umansky found that chondrogenesis was only initiated if the cell density 
exceeded 5000 cells/mm2.5  Furthermore, the cells within the condensation must 
communicate and act together as a unit in order for differentiation to occur.  All 
cells present must be of the same differentiation type and be at the same stage of 
differentiation. Chondrogenic differentiation of the cells starts with the 
downregulation of N-cadherin and NCAM to stop growth and decrease 
fibronectin expression. 7 During overt differentiation, the expression of Hox 
genes, signaling of the BMP pathways, and the activation of transcription factor 
sox9 and it’s co-factors, L-sox5 and sox6, lead to the production of collagen II, IX, 





2.3 PROPERTIES AND COMPOSITION OF CARTILAGE 
 
At first glance, articular cartilage appears to be a rather simple, inert tissue, 
lacking blood vessels, lymphatic vessels, and nerves.  Compared with other 
tissues, cartilage seems to have a low metabolic activity (due to the low number 
of cells present, not due to the metabolic activity of the cells).  Upon further 
examination, although only a few millimeters in thickness, its ability to distribute 
loads, its durability and functions indicate that cartilage is a highly complex 
organ with many interactions. 
 
The cartilage tissue consists of cells, extracellular matrix, and extracellular fluid.  
The cells, chondrocytes, occupy roughly 1% of the tissue volume.  Although 
there is only one cell type, the chondrocytes present in each zone of cartilage are 
different in size, shape, metabolic activity and mechanical function.  The 
extracellular matrix adds another 20 to 40% of wet weight in cartilage.  The 
structural macromolecules, such as collagens, proteoglycans, and non-
collagenous proteins, give the cartilage tissue its form and stability.  Water and 
other electrolytes found in the extracellular fluid comprise up to 80 percent of the 
wet tissue weight.  The mechanical properties of the cartilage are dependent 
upon the flow of this extracellular fluid in and out of the tissue and the 
interaction of the negatively charged proteoglycans with the electrolytes in the 
fluid.   
 
Cartilage is divided into four zones from the articular surface to the subchondral 
bone: superficial, middle, deep, and calcified cartilage. (FIGURE 2.2)  Each zone 
has a different extracellular macromolecular composition and the cell 
morphology and function also vary accordingly.  This zonal organization is very 
important to the overall mechanical function of the tissue.10 
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The superficial zone is the thinnest zone, but it serves as the first mode of 
protection from mechanical and biologic stresses.  The chondrocytes in this zone 
are ellipsoid in shape and are oriented parallel to the articular surface.  The 
extracellular matrix surrounding the cells is a dense network of collagen fibrils 
that are also oriented parallel to the surface.  The orientation of the collagen 
fibrils increase the tensile stiffness and help resist shear and compressive forces.  
The dense network of collagen also serves as a barrier and filter for larger 
proteins, such as antibodies and other inflammatory proteins.  This zone contains 
the highest concentration of collagen and water, but the lowest amount of 
proteoglycans (PG).   
 
The middle zone is a transitional layer which has both elements of the superficial 
and the deep zones. The chondrocytes are spheroid and have higher 
proteoglycan synthesizing capabilities than chondrocytes in the superficial zone.  
The extracellular matrix consists of a lower concentration of water and collagen 
with larger fibril diameters and higher concentrations of proteoglycans. 
 
The cells and collagen fibrils in the deep zone are oriented perpendicularly to the 
articular surface. The perpendicular orientation further enhances the 
compressive properties of the tissue.  This region has the largest diameter 
collagens and the highest amounts of large aggregating proteoglycans, but the 
lowest amounts of water.  The negatively charged proteoglycans also contribute 
repulsion forces to protect the matrix and cells from compressive stresses. 
 
The tidemark is a curvy demarcation that delineates the separation between the 
non-calcified deep zone and calcified cartilage.  The large perpendicular collagen 
fiber bundles from the deep zone cross past the tidemark and into the zone of 
calcified cartilage. These collagen fibers furcated to form an interlocking network 
that anchors the cartilage tissue to the subchondral bone.11   
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One of the primary functions of cartilage is to absorb mechanical shocks and 
distribute high loads evenly across the underlying bone.  The collagen and PG 
network, cells, and interstitial fluid are organized within the tissue to support a 
high compressive load with very low friction and wear.  The complex interaction 
of cartilage tissue can be separated into three interacting phases: 1) a charged 
solid phase, that is composed of a collagen network that is reinforced by a 
hyaluronan mesh with many linked aggregating proteoglycans, such as 
chondroitin sulphate, keratan sulphate, and other negatively charged 
glycosaminoglycans, 2) the fluid phase, or the interstitial fluid, which is mostly 
water, and 3) the ionic electrolytes present in the interstitial fluid that balance out 
the negative charges of the glycosaminoglycans (GAG).12  The capacity of 
articular cartilage to support load is dependent upon the interaction of these 
three phases.  When a compressive force is exerted upon the tissue, the first 
response is the efflux of the interstitial fluid.  The collagen and PG network is 
then redistributed until equilibrium is achieved between the PG aggregates and 
the remaining interstitial fluid.  Some studies have shown that the interstitial 
fluid pressurization can sustain to 95% of the total load applied, while the 
remaining 5% is supported by the collagen and PG network.13 
 
2.4   DISEASE, DAMAGE, AND HEALING 
 
Deterioration of articular cartilage and alterations in the joint, which lead to loss 
of function and integrity of the articular cartilage, are among the most common 
causes of pain and loss in the quality of life amongst middle-aged and senior 
persons.  The degeneration of articular cartilage is most commonly presented 
clinically as osteoarthritis (OA), where the progressive loss of normal structure 
and function result in the fraying of the superficial zone, decreased 
proteoglycans in both superficial and transitional zones, and the invasion of 
blood vessels from the underlying subchondral bone into the cartilage matrix.  
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Studies indicate that there is an increased prevalence of OA with age, although 
the cause is not due to the ‘wear and tear’ of age and lifelong mechanical stresses.  
Age related changes in chondrocyte function and activity may contribute to the 
disease progression.  Other studies indicate that joint instability, abnormal joint 
anatomy, long term static loading and inadequate muscle strength show greater 
risks for degeneration.  Specific activities, such as repetitive movements that 
cause joint stress, high impact, or torsional loading, may also increase the 
probability of disease.14 
 
The primary reason for the limited ability of cartilage to regenerate is due to its 
isolation from the body.  The only source of metabolites and nutrients for the 
cells is delivered by the interstitial fluid, which is further filtered by the dense 
extracellular matrix. 15  Due to this sheltered environment, very few repair 
mechanisms are activated when damage occurs.  Three types of injuries can 
occur: 1) damage to the extracellular matrix and cells without visible disruption 
to the surface of the cartilage, 2) partial thickness cartilage lesions with fractures 
and ruptures, and 3) full thickness osteochondral lesions.16   
 
The first type of injury is damage to the cartilage matrix and cells without a 
visible disruption on the cartilage surface.  The first response of damaged 
chondrocytes to a traumatic injury is to undergo apoptosis.  The process of 
apoptosis is thought to help regeneration and stimulate the neighboring cells to 
increase proliferation and matrix production to account for the degeneration and 
apoptosis.  Depending on the extent of the damage, the tissue may be 
regenerated or if the tissue loss is significant, then a lesion may develop and lead 
to further degeneration and possibly to the formation of a partial thickness 
defect.   
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The response to a partial thickness defect, where the subchondral bone is not 
penetrated is similar to the superficial injury.  There is apoptosis, limited cell 
proliferation and a slight increase in matrix deposition.  Synthesis of a new 
matrix and cellular proliferation will fill the defect partially.  Depending upon 
the location and size of the lesion, the lesion may lead to further instability or if 
structural integrity is present the lesion may not deteriorate any further. In most 
cases, defects smaller than 2 mm2 it will heal completely, but defects larger than 2 
mm2 will lead to further matrix degeneration and cell death.17 
 
If the defect penetrates the subchondral bone, then a spontaneous healing 
response is observed.  A blood clot forms as the foundation for the influx of 
growth factors and mesenchymal progenitor cells.  Generally in mature cartilage, 
two to three months following the injury, repair tissue forms a new layer of bone 
and fibrocartilage.  But upon further examination, the repair tissue has high 
amounts of type I collagen and substitute proteoglycans that are not usually 
found in articular cartilage.  This fibrocartilage formed lacks the required 
mechanical properties and will degenerate over the next 6 – 12 months.18 
 
The quality of repair tissue that is formed after injury to cartilage is dependent 
not only upon the size and depth of the defect, but also upon the age of the 
individual, as shown in a study conducted by Johnstone and Yoo. 19   The repair 
response was compared between 5 week and 4 month old rabbits.  Full thickness 
defects 2 mm in depth were created in the trochlear groove and the repair tissue 
was assessed after 12 weeks.  The results showed that the younger rabbits were 
able to completely regenerate hyaline-like cartilage with a new tidemark 
distinctly dividing newly formed cartilage and bone.  The new tissue was also 
fully integrated with the non-damaged tissue.  At the time of injury, the cartilage 
extracellular matrix was still developing in the younger rabbits, so the number of 
pluripotent mesenchymal stem cells that infiltrated the defect site and the 
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biosynthetic activity of the immature cartilage cells were high enough to 
regenerate the tissue.  In the older rabbit, however, fibrocartilage and scar tissue 
replaced the defect.  The metabolic activity of chondrocytes decreases with age, 
as does the number of pluripotent mesenchymal stem cells present in the 
subchondral bone.  The weak repair response in the older rabbits is due to the 
presence of fewer numbers of chondrocytes that are able to increase extracellular 
matrix production to repair the defect and decreased numbers of mesenchymal 
stem cells that infiltrate the defect from the subchondral bone that are able to 
differentiate chondrogenically.  The ratio of proteoglycans also changes with age, 
and as the concentration of lower molecular weight proteoglycans increases, the 
mechanical strength of the tissue decreases and makes it more susceptible to 
damage. 
 
2.5 CLINICAL THERAPIES 
 
Many of the clinical approaches to repairing cartilage defects exposes the 
subchondral bone to initiate a spontaneous healing response that brings 
mesenchymal stem cells and appropriate growth factors.  The outcome of these 
treatments depends upon many factors, such as the age of the patient, the post-
operative rehabilitation, defect size, and the condition of the joint.  Determining 
the success of a treatment is ultimately assessed by the quality of the repair tissue 
that is generated, the biochemical composition of the repair/regenerated tissue, 
the integration between the new and native cartilage, and its response to 
mechanical stresses.  These factors must be taken into account when evaluating 
the repair tissue and also treatments for defects. 
 
Current therapeutic approaches to cartilage injury include various types of 
shaving or drilling into the surface of the cartilage or transplanting autogenic 
chondrocytes to the defect (autologous chondrocyte implantation, ACI).  
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Methods that do not penetrate the subchondral bone, such as debridgement and 
abrasion arthroplasty, are generally used when defects are less severe. For more 
degenerative conditions, microfracture or mosaicplasty are used to help repair 
the defect by puncturing the subchondral bone and promoting spontaneous 
healing. 20  
 
For single defects located in the femoral condyle or patella, autologous 
chondrocyte implantations (ACI) may be used to repair the defect.21 (FIGURE 
2.3)  During an initial arthroscopy, the damaged area is assessed and 200 to 400 
mg of articular cartilage is harvested from a non-loading bearing area, such as 
the trochlea or the intercondylar notch.  Chondrocytes are isolated from this 
tissue and expanded by monolayer culture in vitro.  Three to six weeks later, the 
patient returns for the second half of the ACI procedure.  The expanded 
chondrocytes, usually between 10 – 20 million in number, are prepared for 
implantation by trypsinization and resuspension in DMEM.  The damaged tissue 
is debrided down to the subchondral bone.  A periosteal implant is harvested 
from the proximal tibia and sutured to the bottom of the defect.  The cell 
suspension is then injected into the defect site.  The periosteal implant serves as a 
barrier to retain the injected cells at the defect site.  The periosteum also contains 
pluripotent cells that have the potential to differentiate into chondrocytes.  
Furthermore, endogenous expression of TGF-β by the cells in the periosteum 
provides a source of biofactors that encourage cartilage development.22,23 
 
Compared to the treatments mentioned previously, ACI have high success rates 
(89-92%) for single defects in the patella or condyle and patients under 35 seem 
to generate better repair tissue.24  Defects ranging between 1 and 16 cm2 and up 
to 8 mm in depth are reparable with good results, given that no other 
degenerative diseases or other changes distress the repair site.25  A few 
randomized clinical studies have compared these techniques to assess the ability 
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to generate hyaline cartilage.  Since these studies were only conducted one or 
two years prior, it is hard to compare the repair tissue generated after these 
treatments without longer-termed evaluations.  In two studies, one comparing 
mosaicplasty to ACI and another comparing microfracture to ACI, found that 
there were no significant differences between the patient scores or the histology 
of the repair tissue.26,27  
 
Despite the high success rates, there are still major disadvantages to chondrocyte 
implantation. The use of ACI for multiple lesions, degenerative diseases, such as 
osteoarthritis, and repair of defects located at other cartilaginous surfaces is poor.  
Long term assessment of the repair tissue suggests that there are also 
complications attached to the use of periosteal grafts that may limit the quality of 
the repair tissue.  The first is the sensitivity of the periosteal implant to drying; 
prolonged exposure (over 5 min) of the implant to air is very detrimental to the 
graft. Drying drastically inhibits neocartilage formation and collagen II 
expression of the explant.28  Furthermore, between 18 – 25% of patients that have 
had ACI treatment develop fibrous and hypertrophic repair tissue, and in the 
worst cases, calcified tissue and ectopic bone may form at the defect site.  The 
development of hypertrophic graft edges lead to poor graft integration and 
delamination.  This leads to symptoms such as locking, instability, or pain that 
require further treatment and surgery.29 
 
In recent years, improvements upon the ACI technique have been made to make 
the surgery less invasive and reduce the risk of hypertrophic tissue development.  
The procedure is very similar to ACI, donor chondrocytes are still harvested, but 
the periosteal graft is replaced with a matrix seeded with the expanded 
chondrocytes.  Currently, there are a few matrices undergoing clinical evaluation 
for use as matrix-based autologous chondrocyte implantation devices.   The use 
of these implants seeks to decrease the cell morbidity, increase cell retention at 
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the defect site, reduce implant hypertrophy, and simplify the surgical procedure.  
The replacement of the periosteal graft with a collagen or a hyaluronan matrix 
allows the cells to be loaded into the scaffold and cultured in vitro prior to the 
implantation.  Seeding the cells onto the implant prior to the surgery allows 
greater cell retention within the matrix and it also gives the cells time to adjust, 
redifferentiate, proliferate, and start depositing an extracellular matrix within the 
implant.  Without the removal of a periosteal graft, the surgical time is reduced.  
Many of these implants can be fixed to the defect site using fibrin glue, which 
further reduces the surgical time.   
 
Some examples of these implants used in conjunction with ACI are shown in 
Figure 2.3.  Chondro-Gide is a mesh-like matrix made from a combination of 
collagen I and collagen III.  The implant has a rough collagen surface on one side 
for cell seeding and on the other surface, a higher collagen density and smoother 
surface prevents fibroblast invasion into the implant.  The short term results (1 – 
3 years) of the matrix-induced autologous chondrocyte implantation (MACI®) 
show comparable tissue formation and graft hypertrophy was reduced to 6%. 30  
Another implant that is being used is Hyalograft C, also a mesh-like matrix, that 
is made from hyaluronan ester.31,32  Hyaluronan is a natural biologic found in the 
joint and many studies have shown positive cell response to injections of 
hyaluronic acid into the joint space and as well as matrices made from 
hyaluronan.33,34  Instead of a mesh-like matrix, Ars Arthro is in clinical trials with 
a collagen I hydrogel (CaReS®) that reduces the in vitro expansion time period, 
which reduces dedifferentiation of the cells.  The CaReS® implant also has some 
viscoelastic properties that are comparable to articular cartilage.  With all of these 
new implants, it is still too early to determine if the pre-culture time in vitro is 
more beneficial for the long term repair, if the degradation of the implants affects 
the repair tissue and how the repair tissue compares with other treatments. 
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The incorporation of scaffold matrices with the ACI procedure to spatially 
organize the cells within the defect is currently being evaluated, but these 
meshes and hydrogels do not have the mechanical properties required to protect 
the developing tissue from joint stress.  Since the clinical trials for these matrices 
are still in the early stages, it remains to be seen how stable the repair tissue will 
be within these matrices.  Thus, this is an area where cartilage tissue engineering 
research can be applied to generate a better repair construct within load-bearing 
scaffolds.   
 
2.6 CARTILAGE TISSUE ENGINEERING 
 
The prevailing dilemma with cartilage regeneration is a lack of cells that are 
capable of repair, a lack of growth factor stimulation and a lack of spatial 
organization for the cells.  Successful strategies for tissue engineering cartilage 
combine responsive cells in sufficient numbers, appropriate biological signaling 
factors, and biocompatible scaffold matrices to address this issue.  A combination 
of these three factors is used to create microenvironments that simulate the 
cellular condensation stage of cartilage morphogenesis.  Environmental 
conditions, such as high cellular density, low permeability, and 
chondroinductive biomolecules, have been found to increase chondrogenesis and 
enhance the quality of the repair tissue.5   
 
The potential candidates for each of the three key elements and how they aid in 
the regeneration of cartilage are reviewed in this section, along with their 
advantages and disadvantages.  First, there are two predominant cell sources 
being investigated for the regeneration of cartilage, chondrocytes and adult 
mesenchymal stem cells (MSC) derived from the bone marrow.  Both of these cell 
types are responsive to an established growth factor cocktail, which induces 
chondrogenic differentiation and promotes extracellular matrix production.  The 
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final factor discussed are the biomaterial scaffolds.  The scaffolds can be 
classified into two major categories: 1) conventional sponge, mesh, and hydrogel 
matrices and 2) computer designed scaffolds made with solid freeform 




There are two cell sources that are currently under investigation for cartilage 
repair/regeneration: chondrocytes and adult mesenchymal stem cells (MSC).  
Sources for autologous chondrocytes are limited and the explant areas required 
to repopulate the defects are large.  At many of these explant sites, the removal of 
cartilage results in fibrocartilage development and further cartilage 
degeneration. As described earlier, in order to attain the number of cells required 
for repairing defects, the chondrocytes are cultured in vitro in monolayer.  Many 
studies have shown that monolayer culture and cell expansion alters the 
chondrocytic phenotype. The chondrocytes become fibroblastic and lose their 
ability to synthesize collagen II and other cartilage proteins.35 The repair tissue 
formed using these expanded chondrocytes is weaker than the tissue regenerated 
by non-passaged chondrocytes.36,37 
 
Current research indicates that adult MSC may be a better regenerative cell 
source for cartilage repair.  MSC are derived from bone marrow aspirates and are 
cultured as a heteropopulation of cells termed bone marrow stromal cells 
(BMSC) or a purified population with cell markers that are indicative of 
multipotentcy (MSC).  Both populations of cells are pluripotent and retain the 
capacity to differentiate into osteoblasts, chondrocytes, adipocytes, myocytes, 
and even neurons when cultured with the appropriate differentiation factors.38,39  
These cells are the adult versions of the cells that participate in the mesenchymal 
condensations during embryonic cartilage morphogenesis.  The use of MSC or 
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BMSC alleviate the need for donor chondrocytes, since they can be isolated from 
most individuals and cultured as an autologous source of cells.  Not only is the 
removal of these cells less taxing on the body, but some studies have shown that 
the repair tissue is more hyaline-like than the tissue formed by committed 
chondrocytes.40  
 
The extracellular environment also affects the capability of the BMSC to 
differentiate into chondrocytes.  Both high density culture and the scaffold 
material affect the cell-cell and cell-matrix signaling mechanisms which influence 
BMSC differentiation.  A key factor for inducing BMSC into chondrogenic 
differentiation in vitro is high density cell culture or minimizing cell attachment 
to the substrate.  The cell shape and the maintenance of a spherical morphology 
is also an important factor to consider.  An established method for chondrogenic 
differentiation was introduced by Yoo and Johnstone.41,42  The scientists 
developed a technique of culturing limb-bud mesenchymal cells in high density 
pellets in vitro to study the process of embryonic chondrogenesis and 
endochondral ossification.  Recently, these cellular pellet cultures have been used 
to maintain cell phenotype and induce cell differentiation. 43,44  High density cell 
pellet cultures help prevent dedifferentiation of chondrocytes in vitro45,46 and 
induce BMSC to differentiate into chondrocytes.47,48  The drawback with this 
method is that the maturation of the cells into hypertrophy is accelerated.  After 1 
week of culture, the presence of collagen X in the matrix is seen.  The appearance 
of collagen X leads to vascular invasion of the extracellular matrix and eventually 
to bone formation.  Furthermore, the fabrication of these high density cell pellets 
is time consuming and difficult to mass produce.  Therefore, the discovery of 
new methods to create cellular aggregates that are less time intensive and inhibit 
maturation by combining cellular aggregates with growth factors will improve 
upon the current techniques used to stimulate chondrogenesis in vitro. 
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2.6.2 Chondrogenic Growth Factors 
 
Biofactors will be used to stimulate the BMSC and chondrocytes into 
chondrogenic differentiation and extracellular matrix production in vitro.  These 
biofactors will simulate the in vivo environment and give specific signals to the 
cells to activate the chondrogenic pathways.  Previous experimentation has 
shown that without the addition of the chondrogenic biofactors, BMSC in cell 
pellets do not aggregate and do not differentitate.42   
 
The defined chondrogenic media used in the experiments for this thesis consists 
of high glucose Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% Fetal 
Bovine Serum (FBS) and 1% Penicillin/ Streptomycin (PS) supplemented with 10 
ng/mL transforming growth factor-β1 (TGF-β1), 5 µg/mL insulin, 100 nM 
dexamethasone, 50 µg/mL 2-phospho-L-ascorbic acid, 0.1 mM non-essential 
amino acids, and 0.4 mM L-proline. Using this defined media formulation, 
Martin et al. found that a combination of dexamethasone, insulin, and TGF-β1 
increased collagen, sulfated glycosaminoglycans (sGAG) and DNA content in 
poly-glycolic acid (PGA) meshes seeded with bovine BMSC.49 
 
Each of the elements in the chondrogenic media provides a signaling factor to 
induce differentiation or provide the nutrients required for extracellular matrix 
deposition and cellular metabolism.  The essential biofactors in the media are 
TGF-β, dexamethasone and insulin.  Their roles will be described further below.  
The other components, such as the proline and non-essential amino acids, are not 
found in the DMEM formulation, but are required for collagen morphogenesis.  
Ascorbic acid is an organic acid which also aids in extracellular matrix 
production.  The addition of exogenous ascorbic acid to micromass cultures 
doubled the amount of sGAG when compared to cultures without ascorbic 
acid.50 
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A combination of TGF-β, dexamethasone, and insulin significantly increased the 
amounts of DNA, GAG, and collagen over groups with dexamethasone alone or 
dexamethasone and insulin.49 The combination of these three elements stimulates 
multiple signaling pathways that eventually lead to the chondrogenic 
differentiation of BMSC.  The paragraphs below present an overview of the 
observed effects these biofactors have on BMSC differentiation.   
 
The primary signaling factor in the chondrogenic media is TGF-β.  Both TGF-β1 
and TGF-β3 enhance BMSC differentiation into chondrocytes by increasing 
cellular proliferation presumably beyond a critical density that is required for 
chondrogenesis. 51,52 TGF-β also helps initiate cellular condensation by regulating 
the expression of fibronectin.5  Increased expression of type II collagen mRNA 
and other extracellular matrix proteoglycans are also associated with TGF-β 
signaling.  Cell aggregates cultured in a series of TGF-β1 and then IGF-1 
increased the markers of chondrocytic function, such as proteoglycan content 
and procollagen type II mRNA.53   
 
Chondrocytes and BMSC have cell receptors that have a high affinity for both 
insulin and IGF-1.54  Insulin is intimately involved during the progression and 
the onset of chondrogenesis.55 It stimulates both growth-promoting and 
metabolic activities in chondrocytes.  It has been also shown to increase cell size 
and act synergistically with amino acids to promote sulfate incorporation in 
cartilage.56   
 
Dexamethasone functions to support cell viability and modulate cellular 
activities of differentiating cells.55  In a study on the effects of dexamethasone 
and human BMSC formation of bone in vivo, dexamethasone increased the 
reproducibility of bone formation between patients and increased bone forming 
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ability of lower capacity BMSC.57 In another study, the addition of 
dexamethasone induced chondrogenesis of mouse progenitor cells.49 
 
The addition of some growth factors that are in the defined chondrogenic media 
may cause dedifferentiation or alteration of the metabolic activity of the 
committed chondrocytes.  The chondrogenic defined media for the committed 
chondrocytes used in this thesis will not contain TGF-β1 and dexamethasone.  
Both have been shown to have a detrimental affect on the cellular metabolism of 
chondrocytes. An inverse proportional relationship was found between the 
concentration of dexamethasone and expression of type X collagen mRNA.55  The 
effect of TGF-β1 has been studied on cartilage explants, osteoarthritic tissue, and 
chondrocytes grown on both monolayer and in three-dimensional culture.58  
Most studies found that TGF-β is detrimental to DNA and proteoglycan 
synthesis.54,59  TGF-β also changed the cellular morphology of the chondrocytes, 
making them appear flattened and more fibroblast-like.60  The combination of 
FBS and TGF-β decreased collagen II and proteoglycan synthesis in addition to 
the fibroblastic morphology in equine chondrocytes that were cultured in a fibrin 
gel.61 Other studies showed that interarticular injections of TGF-β caused 
osteoarthritic-like pathology and induced the formation of osteophytes in murine 
cartilage.62     
 
2.6.3 Biomaterial Scaffolds 
 
Scaffold design, architecture and biomaterial are also important considerations in 
the tissue engineering of cartilage because the scaffold serves many purposes in 
aiding the regeneration of tissue.  The main role of the scaffold is to provide a 
spatial framework that fills the defect space.  Without a scaffold matrix to define 
the extents of the defect void, the repair tissue, even with the addition of cells 
and biofactors, would still incompletely fill the defect.63  Other desirable scaffold 
 24
properties include increasing cell retention and serving as a template for the 
repair tissue. Ideally, the scaffold material should be biocompatible, 
biodegradable, and slowly degrade over time so that the generation of the repair 
tissue and the degradation of the scaffold are matched.  Furthermore, the scaffold 
material should also facilitate cell attachment and aid in the integration of repair 
and native tissues. Cell interactions with scaffold biomaterial can influence 
BMSC differentiation and can promote extracellular matrix formation.64,65 
Another important consideration are the biomechanical properties of the 
scaffold. The scaffold should provide mechanical support to protect the 
developing tissue.66  Ideally the physical properties of the scaffold should match 
the native tissue. Some studies have shown that improperly matched scaffold 
constructs lead to tissue degeneration.20 Mechanical assessment of articular 
cartilage taken from various joints show compressive moduli between 0.4 – 0.8 
MPa, shear moduli between 0.2 – 2 MPa, and tensile values ranging between 0.32 
– 10.2 MPa.67 
 
Conventional scaffolds for cartilage tissue engineering consist of porous non-
woven meshes, sponges, and hydrogels made from a variety of poly(α-hydroxy) 
acids, poly(ethylene glycol), other synthetic polymers, and also natural biologics, 
such as collagen, hyaluronan, chitosan, and alginate.68,69,70,71,72 All of these 
scaffold matrices facilitate new tissue growth by providing spatial organization 
for the cells and aiding in cell retention.  The porous matrices have high porosity 
and high surface areas for cell attachment. Often times the pores of these 
scaffolds are highly tortuous and small in size which hinders cell migration and 
diffusion. Another disadvantage of these matrices is their poor mechanical 
integrity. If implanted at an orthotopic site, many of these implant devices would 
ultimately fail because both the scaffold and developing tissue would not be able 
to withstand the forces.  For example, autologous articular chondrocytes were 
seeded into type II-collagen sponges and cultured for 4 weeks in vitro prior to 
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implantation in chondral defect in a canine model.  After 15 weeks, the 
reparative tissue filled 88% of original defect, of which 42% was hyaline tissue.  
Stiffness from indentation tests still showed that the reparative tissue had 
properties that were 20 times lower that of articular cartilage.73  In another study 
conducted with alginate hydrogels seeded with chondrocytes, the equilibrium 
tensile modulus measured after 2 weeks of in vitro culture was lower than 10 
kPa.74  This value is significantly lower than the tensile modulus for articular 
cartilage, which is around 25.5 MPa.75  New technologies and advances in 
nanofibers and weaving may introduce methods to improve upon the 
mechanical properties of these conventional matrices.  Moutos et al. developed a 
construct that is made from uniquely woven multifilament polyglycolic acid 
(PGA) fiber that has a diameter of 104 µm.  Chondrocytes were seeded into these 
scaffolds and the mechanical properties were assessed. The biomechanical 
properties of the scaffolds were within the same order of magnitude for 
compressive, tensile and shear properties of articular cartilage.76 
 
An alternative method of scaffold fabrication has developed with the 
advancement of rapid prototyping systems, known as solid freeform fabrication 
(SFF). SFF has improved the physical properties of tissue engineering scaffolds 
and expanded the possibilities beyond traditional sponges and hydrogels.  The 
number of controllable design inputs has greatly increased due to the ability to 
interface computers and the rapid prototyping machines. Computer 
programming and design allow the user to custom-design the shape of an 
implant, control the scaffold porosity, pore interconnectivity, and even design 
mechanical reinforcements to account for biomaterial degradation.77  Another 
significant benefit is the load-bearing properties of most designed SFF scaffolds.  
The tested mechanical properties are within the range of or greater than native 
cartilage.  Furthermore, SFF can be used with a variety of biomaterials.  Many 
SFF scaffolds have been made from both synthetic and natural polymers.78,79,80,81  
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There are a variety of rapid prototyping systems available currently, from fuse 
deposition modeling (FDM), solid laser sintering (SLS), solid freeform fabrication 
(SFF) to organ printing systems which print viable cells and matrices into three-
dimensional constructs.  The success of the scaffolds to promote new cartilage 
tissue formation has been shown by many studies, both in vivo and in vitro.  
Some studies show that these SFF scaffolds are better for cellular retention and 
for increasing extracellular matrix formation. In a study conducted by Miot et al., 
the ability of chondrocytes to redifferentiate and deposit extracellular matrix was 
compared between compression molded scaffolds (which are comparable to 
conventional sponge scaffolds) and FDM scaffolds.  They found that the larger 
pore volumes of the FDM scaffolds were better for chondrocyte activity, showing 
increased sGAG and collagen II production.  It is assumed that the difference 
was due to higher permeability, lower connective density, and lower tortuosity 
of the FDM scaffolds.82 In another study, similar compression molded and 3D 
fiber deposition (3DF) scaffolds were used to evaluate cell migration into the 
center of the scaffolds over time. The results showed significantly greater 
numbers of cells present at the center of the 3DF scaffolds.83   
 
Many novel scaffold designs have been created using these rapid prototyping 
systems.  For example, a scaffold with the anisotropic zonal organization that is 
present in articular cartilage was created using 3D fiber deposition.  The scaffold 
was divided into 3 zones: the deep with 2 mm spacing between fibers, the 
middle with 1 mm spacing, and the superficial layer with 0.5 mm spacing.  When 
seeded with chondrocytes, the scaffold promoted anisotropic cell distribution 
that correlated with three zonal spacings.  Although the level of GAG/DNA was 
similar across the zones, the amount of collagen II and GAG content was greater 
in the ‘deep’ zone where there was larger zonal spacing.84 Other examples 
include scaffold designs with honey-comb like pore structures and auricle 
shaped constructs.35,85  
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There are infinite possibilities for scaffold design due to the various types of 
rapid prototyping systems available and the number of possible design inputs.  
Many of the controllable scaffold properties, such as porosity, pore size, and pore 
shape and scaffold permeability have not been investigated to determine which 
design inputs are more effective in stimulating chondrogenesis.  Through 
computer design and manipulation of these inputs, isolation of scaffold design 
variables can be used to evaluate their influence on cell behaviour.   
 
For example, scaffold permeability is one such parameter that has not been 
investigated. Scaffold permeability affects the diffusion of nutrients and oxygen 
into the scaffold.  The diffusion of nutrients ultimately affects the cell metabolism 
and extracellular matrix formation.  Although studies have been conducted on 
how oxygen tensions affect chondrocytic behaviour in both BMSC and 
chondrocytes, there are no studies on how scaffold permeability may influence 
chondrocytic activity or even any studies relating scaffold permeability to 
oxygen tensions. Research that have been conducted show that periosteal 
implants cultured in lower oxygen tensions (12-15%) produced the most GAG 
and collagen compared to other groups (1-5%, 12-45%, and 90% O2).86 Rat 
mesenchymal stem cells cultured at low oxygen tensions (5%) had greater 
number of colonies and proliferated more rapidly than cells cultured at 20% 
oxygen.87  There is also evidence that at lower oxygen concentrations, the cells do 
not ‘age’ as quickly presumably due to the reduction of free radicals.88   
 
In a study of oxygen tension levels within SFF scaffolds, Malda et al. found that 
an oxygen gradient exists between the edge and the center of the scaffolds.  The 
oxygen tension levels out to a non-zero plateau, which indicates that oxygen is 
not the limiting factor at the center of these scaffolds.  It is known that in the 
deep zone of cartilage, chondrocytes mainly use glycolysis to generate energy, so 
glucose may be the limiting factor.83 Heywood found that culturing 
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chondrocytes in media with low glucose levels upregulates oxygen consumption 
and inhibits glycolysis.  This finding further indicates that glucose is a key factor 
in regulating aerobic respiration within tissue-engineered constructs.89  Since the 
scaffold permeability and diffusivity will affect both the glucose concentration 
and oxygen tension, it will be important to investigate the relationship between 
these factors.  
 
Another scaffold design property that can be easily changed with SFF design is 
the scaffold pore size.  The effects of scaffold pore size on the regeneration of 
cartilage have not been studied extensively, although changes in pore size will 
affect the cellular densities.  A few studies have been conducted in conventional 
sponge matrices, where the pore sizes are smaller than 250 µm.90,91 Yamane et al. 
examined the pore sizes ranging between 100 and 400 µm in chitosan-hyaluronic 
acid woven fiber scaffolds.  They found that the 400 µm pore showed greater 
areas of cartilage and higher numbers of chondrocytes.92  Specific studies looking 
at SFF scaffold pore sizes and cartilage regeneration have not been conducted.  It 
is suggested that SFF scaffolds with pore interconnection sizes between 300 – 500 
µm can help facilitate diffusion into the center of the SFF scaffolds that were 




Conventional cartilage tissue engineering scaffolds have been able to support 
chondrogenesis, but do not have adequate mechanical properties.  The use of SFF 
scaffolds will not only provide mechanical support to the developing tissue, but 
the ability to design and manipulate scaffold properties will increase the 
knowledge of how physical scaffold properties affect cartilage formation.  From 
the studies reviewed above, it has been shown that simulation of the 
microenvironment that is present during the cellular condensation step of 
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cartilage morphogenesis can enhance the chondrogenic activities of BMSC and 
chondrocytes.  The studies in this thesis will investigate how to enhance 
chondrogenesis within SFF scaffolds by directing cellular condensation through 
chondroinductive biomolecule, hyaluronic acid, and chondroconductive pore 
geometries that mimic micromass cultures.  The effects of these factors will be 
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EFFECTS OF CHONDROINDUCTIVE BIOMOLECULE, 




Many types of hydrogels have been explored for providing a three-dimensional 
environment that maintains the chondrocytic phenotype and promotes new 
matrix formation.  These hydrogels alone, as previously stated, have weak 
mechanical properties and are incapable of withstanding forces normally exerted 
at clinically relevant defect sites.1,2  However, combining hydrogels and solid 
freeform fabricated (SFF) scaffolds creates a synergistic construct for tissue 
engineering cartilage.  The hydrogel will stimulate and enhance extracellular 
matrix production and other chondrocytic cellular activities, while the SFF 
scaffold provides the mechanical support to the developing tissue.  The hydrogel 
can increase the cellular retention within the scaffold and also provide a template 
to guide the regeneration of new cartilage tissue. 
 
Collagen is an ideal substrate for cartilage tissue engineering because it can be 
formed in situ, is easily manipulated, and can serve as a natural, biologic delivery 
vehicle for cells and growth factors.  Collagen hydrogels have been explored in 
numerous applications, including regeneration of vocal chords3 and repair of 
spinal cord conduits4 and cartilage defects.5,6  However, collagen I fibrils have 
been shown to destabilize the cellular phenotype, where the chondrocytes 
acquire fibroblast-like morphologies and produce collagen I and collagen X 
instead of collagens II, IX, and XI. 7 , 8  Chondrocytes cultured in collagen I 
hydrogels exhibit reduced proliferation and decreased biosynthetic activity.9,10  
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The addition of hyaluronic acid (HyA) to collagen I hydrogels may help stabilize 
chondrocyte phenotype and increase proteoglycan synthesis presenting a 
possible solution to mitigate the effect of collagen I fibrils. Hyaluronic acid is a 
ubiquitous glycosaminoglycan found in many tissues of the body.  HyA is 
synthesized in large quantities during wound healing to facilitate cell motility 
and in fetal healing where it reduces scar formation.11  As described in Chapter 2, 
HyA is also present during the mesenchymal condensation period, where it aids 
the migration of the mesenchymal stem cells to a ‘central’ location and in the 
formation of cellular condensations.  This effect has also been observed in vitro, 
where studies show that the exogenous addition of low concentrations of 
hyaluronic acid (0.1 mg/mL or less added to culture medium) prompted 
chondroprogenitors to form three dimensional clusters and induced 
chondrocytes to produce more collagen II and aggrecan. 12,13  It will be important 
to investigate the concentration of HyA required to promote cellular aggregation 
because the amount of HyA-cell receptor interaction directs the formation of 
cellular condensations.  At low concentrations of HyA, the cells have free 
receptors that are able to bind to HyA that is already bound to a neighboring cell 
(FIGURE 3.1).  This creates a cross-bridge between the cells and meditates 
cellular aggregation.  At higher concentrations of HyA, the receptors become 
saturated because they bind to individual HyA molecules.  The cross-bridging is 
inhibited due to the lack of free receptors, so aggregate formation does not occur. 
 
Furthermore, HyA is an essential mucopolysaccharide that serves as the 
backbone of the proteoglycan network in the extracellular matrix of cartilage.  It 
is also found in the synovial fluid where it acts as a lubricating agent.  HyA is 
also required for maintenance of the pericellular matrix and is partially 
responsible for the characteristic ability of cartilage to withstand compression 
due to its organization and retention of aggrecan and sulfated 
glycosaminoglycans (sGAG) within the extracellular matrix.  Both chondrocytes 
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and BMSC are able to bind to HyA through cell surface receptors, such as CD44 
and RHAMM.  Cellular binding to HyA initiates signals that modulate cell 
proliferation, migration, and differentiation. 14 , 15   The benefits of HyA in 
facilitating chondrogenesis have been shown in several studies.  Bovine 
chondrocytes cultured in gelatin sponges with exogenous high molecular weight 
HyA increase cell retention and proteoglycan synthesis. 16   Chondrocytes 
embedded in collagen I hydrogels cultured with exogenous HyA increase cell 
proliferation and chondroitin sulfate synthesis at 0.1 and 1 mg/mL 
concentrations. 17  Furthermore, chondrocytes cultured in composite 
HyA/alginate beads showed increased sGAG deposition and enhanced 
synthesis of both DNA and hydroxyproline.18 
 
In this study, we evaluated the effects of HyA on BMSC and chondrocyte 
behavior using a combination of composite hyaluronic acid/collagen I hydrogels 
and designed porous SFF scaffolds.  Our hypothesis is that addition of low 
concentrations of high molecular weight HyA to collagen I hydrogels will have a 
beneficial effect on matrix production and phenotype stability.  First, we 
evaluated the metabolism and proteoglycan synthesis of BMSC and 
chondrocytes embedded in composite hyaluronic acid/collagen I hydrogels in 
vitro to determine HyA concentrations with the greatest benefit.  In a separate in 
vivo phase, composite HyA hydrogels were used in combination with designed 
poly(propylene fumarate) (PPF) or poly(ε-caprolactone) (PCL) scaffolds with 
cubic architecture.  Composite HyA hydrogels were used to seed the scaffolds 
with BMSC or chondrocytes and then implanted in mice to evaluate both the 
effects of the hydrogels on maintaining the chondrocytic phenotype and 





3.2 MATERIALS AND METHODS 
 
3.2.1 Cell isolation 
 
Primary porcine chondrocytes were isolated from the metacarpophalangeal 
joints of domestic pigs.  Cartilage slices were extracted aseptically within four 
hours of slaughter.  Chondrocytes were isolated from the tissue using a solution 
of 1 mg/mL collagenase II (Sigma, St. Louis, MO) and antibiotics.  The isolated 
cells were filtered and were allowed to adhere for 24 hours.  The adherent 
chondrocyte population was used for experimentation. 
 
Porcine BMSC were isolated from the bone marrow aspirate of Yucatan minipigs 
(Seguin Animal Hospital, Seguin, TX).  The aspirate was collected in a solution of 
heparin and antibiotics.  The whole bone marrow was cultured for weeks and the 
entire adherent cell population was used for these studies.  The cells were not 
passaged or passaged once prior to use. 
 
3.2.2 In vitro experimentation 
 
In vitro cell culture 
Cells were encapsulated in either collagen I or composite HyA/collagen I gels 
and cultured in either basal or chondrogenic media to determine the combination 
most favorable for chondrogenesis.  After trypsinization, cells were resuspended 
at 3.5 x 106 cells/mL in solubilized collagen I (BD Bioscience Discovery Labs, San 
Jose, CA) with 200 µL of culture medium.  The pH of the collagen/cell 
suspension was increased with the addition of 20 µL of 0.5 M sodium hydroxide 
solution (Appendix C).  The mixture was pipetted in 70 µL aliquots into 96-well 
tissue culture plates.  The resulting collagen I hydrogels were 2.2 mm in height 
and 6.35 mm in diameter. To create the composite HyA/collagen I gels, 
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hyaluronic acid (stock concentration: 2.7 mg/mL in 0.8 M NaCl, MW: 3 x 106 Da; 
Hyalogic LLC,  Edwardsville, KS) was added to the collagen I cell suspension to 
produce 1, 2, 5, and 10% (w/w) HyA/collagen I gels.  The HyA concentrations 
for the corresponding weight percent gels were 0.05, 0.09, 0.23, and 0.47 mg/mL, 
respectively.  The pH was raised to physiologic levels with NaOH as described 
above. (The amount of collagen I used to resuspend the cells in composite 
hydrogels was adjusted so that the final volumes of the HyA/collagen cell 
suspension was similar to collagen I only hydrogels.) All hydrogels were placed 
in an incubator at 37°C and allowed to solidify for 30 minutes. Either basal 
medium or chondrogenic medium (basal medium supplemented with 10 ng/mL 
TGF-β1, 100 nM dexamethasone, 50 µg/mL 2-phospho-L-ascorbic acid, 0.4 mM 
proline (Sigma), 5 µg/mL insulin (Gibco) and 0.1 mM non-essential amino acids 
(Gibco)) was then added to the tissue culture wells.  The defined chondrogenic 
medium for the chondrocytes did not contain TGF-β1 and dexamethasone.  The 
hydrogels were cultured for up to two weeks under gentle agitation on an orbital 
shaker and with the media replaced every other day.  Hydrogels were assessed 
at one week and two weeks for glycosaminoglycan content, cell viability and cell 
number.  Three replicates of each group from three separate experiments were 
used for analysis.  
 
DMMB assay for GAG quantification 
Cultured hydrogels were rinsed with Hank’s Balanced Salt Solution (HBSS, 
Gibco) and then digested with proteinase K at 65°C for 2 hours (Appendix D).  
Samples spiked with known amounts of chondroitin sulphate and empty 
samples with just proteinase K digest solution were used as positive and 
negative controls, respectively. After the gels were completely digested, the 
temperature was increased to inactivate the enzyme.  The digested samples were 
centrifuged through a filter for 10 minutes at 14,000 rpm and the supernatant 
kept.  Dimethyl-methylene blue (DMMB) assay was conducted as described by 
 47
Farndale.19  Since HyA is a non-sulphated glycosaminoglycan, it does not bind to 
DMMB and will not interfere with the sGAG detection.20  Five microliters of 
supernatant from each sample was mixed with 200 µL of DMMB solution and 
525 nm absorbance was read in a spectrophotometer.  Chondroitin sulphate from 
shark cartilage (Sigma) was used to create a calibration curve to correlate the 
measured absorbance to known amounts of sGAG.  Data from the DMMB 
analyses were assessed using the student’s t-test with α = 0.05.  The data between 
the groups was compared using analysis of variance (ANOVA) using hydrogel 
composition and culture medium as the factors for the Tukey post hoc test. 
 
Cell viability and count 
Cell viability and count were determined using the Cell Titer 96® AQueous One 
non-radioactive cell proliferation assay (Promega, Madison, WI). Cell viability 
was determined by reading the 490 nm absorbance of a formazan product 
bioreduced from a tetrazolium compound.  Cell count was also determined 
using this assay via a linear cell standard correlating the amount of formazan 
product formed in a given amount of time and number of cells present.  A 
hemacytometer and coulter counter was used to verify the cell count from 
digested hydrogels and validate the cell standard. The amount of DNA present 
was calculated from the cell number, assuming 7.7 picograms of DNA per cell. 
 
3.2.3 In vivo experimentation 
 
Scaffold design and fabrication 
Image-based design (IBD) techniques21 were used to create cylindrical scaffolds 
with defined internal pore architectures.  The external dimensions of all designed 
scaffolds were 3.5 mm in height and 5 mm in diameter.  Unitcells, the basic 
repeating unit of a 3D periodic structure, for cubic pore designs were [0.7 mm, 
0.7 mm, 0.7 mm] (FIGURE 3.2a).  The strut size of the cubic scaffolds was 
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designed to be 350 µm thick, which corresponds to pore space dimensions of 350 
µm in length, width and height.  The designed porosity of the scaffold was 50 
percent. Repeating unitcells were used to create the interconnected pore 
architecture of the scaffolds shown in Figure 3.2b.   
 
Wax molds were printed from design files using a three dimensional rapid 
prototyping system (PatternmasterTM, Solidscape, Inc., Merrimack, NH). The wax 
molds were cast into poly(propylene fumarate) using indirect SFF fabrication 
techniques described previously.22  Briefly, one gram of PPF (MW: 1500 Da) was 
dissolved in one milliliter of N-vinyl-pyrrolidone (NVP).  After homogenization, 
0.02 grams of benzoyl peroxide was added to the PPF/NVP mixture.  Then, two 
microliters of N, N-dimethyl-p-toluidene was added to induce crosslinking 
immediately before casting.23  A custom polytetrafluoroethylene (PTFE) mold 
(diameter = 6 mm) was used to force the polymer solution through the pore 
spaces of the wax molds.  The PTFE mold was placed in a nitrogen chamber at 
room temperature for 24 hours until the polymer cured.  The wax was then 
removed with acetone, and the remaining PPF scaffolds were rinsed in distilled 
deionized water and sterilized in 70% ethanol.  
 
Scaffold Design Verification and Permeability Calculations 
Scaffolds cast in PPF from the wax molds were scanned using a micro-computed 
tomography machine (MS-130, GE Medical Systems, Toronto, Canada) to 
determine the accuracy of the fabrication process.  The scaffolds were scanned in 
air at a resolution of 16 µm.  The measured features were within 5% of the 
designed specifications. 
   
In vitro pre-culture 
In preparation for cell seeding, the PPF and PCL scaffolds were rinsed twice with 
sterile HBSS and once with culture medium.  The scaffolds were then placed in a 
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custom made PTFE mold (diameter = 5.1mm).  Cells were seeded into the 
scaffold pores using a collagen I or 5% HyA/collagen I hydrogel similar to those 
described above. For these hydrogels, 40 x 106 cells/mL were resuspended in a 
solution containing either ~3.8 mg/mL collagen I or 5% (w/w) HyA/collagen I 
after trypsinization.  The pH of the solution was increased, and the cell/hydrogel 
suspension was pipetted into the scaffold pores (~60 µL) immediately after 
sodium hydroxide addition. The gels were allowed to solidify within the 
scaffolds in a humidified chamber at 37°C for 30 minutes.  The PPF scaffolds 
were then removed from the PTFE mold and placed in a 24-well tissue culture 
plate.  Basal culture medium or defined chondrogenic medium was added to the 
wells, and then the plate was placed in the incubator and gently agitated on an 
orbital shaker.  The chondrocyte-seeded scaffolds were pre-cultured for 2 weeks 
with the culture media changed every other day during this period. 
 
In vivo implantation 
After pre-culture, 8 PPF scaffolds seeded with chondrocytes and 16 PCL 
scaffolds seeded with BMSC or fibroblast-like chondrocytes (passage 6) (n = 4 for 
all groups) using either collagen I or 5% HyA/collagen I hydrogels and were 
implanted subcutaneously in 5- to 8-week-old immunocompromised mice 
(N:NIH-bg-nu-xid; Charles River, Wilmington, MA).  The animals were 
anesthetized with intramuscular injections of ketamine (50 µg/g) and xylazine (5 
µg/g) in saline.  Four dorsal subcutaneous pockets were created by blunt 
dissection and one PPF or PCL scaffold from each experimental group was 
placed in each pouch and in a different pouch location in each mouse.  The 
implantation sites were closed with surgical wound clips. The animals were 
housed in groups for four weeks with free access to food and water.  
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Evaluation of implants 
The mice were sacrificed after 4 weeks.  The scaffolds were harvested and fixed 
in Z-FIX (Anatech, Battle Creek, MI) overnight.  The scaffolds were then 
dehydrated and processed for histology.  The specimens were embedded in 
paraffin and sectioned at 7 µm.  Sections were affixed to slides and stained with 
hematoxylin and eosin (H&E) or Safranin O counterstained with fast green FCF. 
 
Histomorphometric image analysis 
Histological sections taken from four separate planes (~500 µm difference) of 
each scaffold and were used for analyses.  Low magnification (2X objective) 
images of Safranin O stained cross-sections were taken using CCD camera (RT 
Color 2.2.1, Diagnostic Instruments, Sterling Heights, MI) mounted on an 
inverted microscope (E600, Eclipse, Nikon, Japan, ETC).  Histomorphometric 
image analysis (Appendix E) was used to quantify the average sGAG 
concentration and the amount of cartilage-like matrix of each plane.  Negative 
controls, composite HyA/collagen hydrogels without cells were also stained 
with Safranin O/Fast Green to verify that the HyA does not stain positively with 
Safranin O. The histomorphometric data was statistically analyzed using 
ANOVA to determine if hydrogels containing 5% HyA promoted more 
chondrogenesis than hydrogels with collagen I alone. All statistical tests were 
performed using SPSS. 
 
Immunohistochemistry (IHC) was used to detect the presence of collagen I and 
collagen II (Appendix F) in the extracellular matrix.  Paraffin sections were used 
for the IHC staining.  Primary antibodies raised in rabbits against human-
collagen I and human-collagen II were used and have been shown to cross-react 
with porcine collagen I and II.  Sections of porcine cartilage were used as positive 
controls and to determine the optimal concentrations for the primary antibodies.  




3.3.1 In vitro evaluation of HyA hydrogels 
 
After two weeks of in vitro culture in either basal or chondrogenic medium, 97% 
– 99% of all cells in all hydrogels remained viable.  Additionally, the number of 
viable cells after 2 weeks in culture was greater compared to that after 1 week in 
culture.  The number of cells increased with increasing concentrations of HyA 
and was also greater in hydrogels cultured in chondrogenic medium compared 
to basal medium.  These results verify that all combinations of medium and 
hydrogel studied are capable of supporting BMSC and chondrocyte activity. 
 
The addition of HyA up to the 5% HyA concentration promoted cellular 
aggregation within the BMSC and chondrocyte seeded hydrogels.  The number 
of aggregates did not increase dramatically from one timepoint to the next.  After 
the initial condensation or aggregation, which appeared over the course of the 
first week, few additional aggregates were seen at the second week timepoint.  
Once the aggregates were formed, however, the cells remained condensed 
together and did not disperse over time.  Culture in the chondrogenic defined 
media also seemed to increase the size of the aggregates present.  Phase contrast 
images of the aggregates within the hydrogels were taken at 1 and 2 week 
timepoints (FIGURE 3.3).  BMSC aggregates of various sizes were seen within the 
composite HyA hydrogels at 1%, 2%, and 5% concentrations.  Numerous small 
aggregates were observed in the 1% HyA hydrogels and as the HyA 
concentration increased, the size of the aggregates increased while the number of 
aggregates decreased.  The largest aggregates were seen within the composite 5% 
HyA hydrogels cultured in chondrogenic media.  Safranin O staining of all 
hydrogels showed active chondrogenesis and matrix deposition in the areas 
surrounding the cellular aggregates.  A limited number of aggregates were seen 
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in 10% HyA/collagen hydrogels or hydrogels with collagen I only, although 
some areas of chondrogenesis stained positive with Safranin O.  Cellular 
aggregates were also observed in the chondrocyte-seeded hydrogels (FIGURE 
3.4).  The 2% and 5% HyA concentrations showed some aggregate formation, 
although the response to the HyA was not as widespread and overt as the BMSC 
aggregates. 
 
The results from the DMMB quantification of the sGAG content within the HyA 
hydrogels further confirmed the increase in extracellular matrix production by 
both BMSC and chondrocytes.  A trend was observed, where increasing amounts 
of HyA (up to 5% HyA) resulted in increased amounts of sGAG/DNA ratios 
measured.  The 10% HyA hydrogels seeded with BMSC and chondrocytes 
exhibited mixed behavior that was in some instances greater than hydrogels with 
collagen I only (controls) and in other cases lower than expected. 
 
Analysis of the sGAG/DNA data for BMSC seeded hydrogels indicated that 
some concentrations of HyA may be better for aiding chondrocytic 
differentiation and extracellular matrix formation.  The sGAG/DNA HyA 
hydrogels for the first week of culture showed low amounts of sGAG production 
(FIGURE 3.5a), although all additions of HyA increased the sGAG/DNA content 
over the control hydrogels (p < 0.01).  Culture in the chondrogenic defined media 
increased amounts of sGAG over control hydrogels, but of greater interest is the 
larger increase in sGAG/DNA in the 5% and 10% HyA hydrogels.  The 
sGAG/DNA ratio of the 5% HyA hydrogels cultured in chondrogenic media is 
significantly greater than all other groups (p < 0.05).  After two weeks of in vitro 
culture, the sGAG/DNA ratios of all the hydrogel groups increased by at least a 
factor of two over the one week data, except for the 10% HyA group that was 
cultured in basal medium (FIGURE 3.5b).  Once again, the 5% HyA hydrogel 
group showed highest sGAG/DNA ratio compared to all groups (p < 0.01).  This 
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result occurred regardless of the culture media used, thus indicating that the 
amount of HyA maybe able to stimulate chondrogenesis without the addition of 
exogenous growth factors. 
 
The addition of HyA to chondrocyte-seeded hydrogels generally resulted in 
increased sGAG deposition compared to hydrogels with collagen I alone, 
irrespective of the culture medium or the culture duration.  After one week of 
culture, the 1%, 2%, and 5% HyA hydrogels cultured in basal medium increased 
the sGAG/DNA ratios over the controls and the 2%, 5% and 10% HyA hydrogels 
cultured in chondrogenic media had greater sGAG/DNA ratios over controls 
(Figure 3.5c).  The 5% HyA hydrogels had the greatest sGAG/DNA ratio over all 
other groups (p < 0.05).  The sGAG/DNA ratios of chondrocyte seeded 
hydrogels after two weeks of culture are shown in Figure 3.5d.  At two weeks, 
sGAG quantification of the hydrogels containing HyA that were cultured in 
basal medium were significantly increased over controls (p < 0.05).  Of the HyA 
hydrogels cultured in chondrogenic media, only the 5% HyA group was greater 
than the controls (p < 0.01), while all others were similar to control values. 
Comparison of the one week and two week results showed that sGAG/DNA 
increased significantly for all hydrogels (composite and controls) cultured in 
basal medium and conversely decreased, though not significantly, for hydrogels 
in the chondrogenic medium.  The results for the chondrocytes are not as clearly 
resolved as the BMSC data, although the 5% HyA group seems to increase GAG 
synthesis in chondrocytes as well. 
 
Among all combinations of hydrogel and culture medium, the highest amount of 
matrix formation, as quantified by the amount of sGAG normalized by the 
amount of DNA, was obtained with a 5% composite hydrogel cultured in 
chondrogenic medium for BMSC and a 5% composite hydrogel cultured in basal 
medium for chondrocytes. These combinations were thus chosen to seed BMSC 
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and chondrocytes, respectively, into PCL or PPF scaffolds that subsequently 
were implanted into mice in in vivo experiments. 
 
3.3.2 In vivo comparison of HyA hydrogels 
 
Two studies were conducted to assess the effects of 5% HyA on cartilage 
formation during in vivo implantation.  In the first study, PCL scaffolds were 
seeded with BMSC using either 5% HyA/collagen or collagen I hydrogels and 
cultured for 2 weeks in vitro in defined chondrogenic medium.  In the second 
study, PPF scaffolds were seeded with chondrocytes using either 5% 
HyA/collagen or collagen only hydrogels and cultured for 2 weeks in vitro in 
basal medium.  All scaffolds were implanted and the mice survived surgery 
without complication.  All mice lived 4 weeks without signs of abnormality.  All 
implanted scaffolds were extracted, found intact, and processed for histological 
analysis. 
 
Microscopic examination of the tissue/scaffold sections showed widespread 
positive Safranin O staining of the pore spaces confirming the presence of sGAG 
and viable chondrocytes. Chondrogenically differentiated BMSC and 
chondrocytes filled the pore spaces of the scaffolds and were surrounded by 
dense extracellular matrix, which stained positive with Safranin O. The general 
morphology of the cells was round and chondrocytic in appearance with 
established lacunae, even at the center of the scaffolds. (FIGURE 3.6:a4, b4, c4, 
d4) Within these same sections some areas counterstained with fast green 
indicating the presence of non-cartilaginous matrix.  Spindle-shaped fibroblast-
like cells and endothelial cells were found in these areas, which were primarily at 
the edges of the scaffolds and in scaffold pores where cells were embedded in 
collagen I.  A greater number of cells within the scaffolds with collagen I only 
hydrogels stained positively with fast green, indicating that extracellular matrix 
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surrounding the cells did not contain sGAG and that the cells may have lost the 
chondrocytic phenotype and the ability to produce sGAG.  Greater areas of cells 
that stained positively with fast green were seen within the scaffolds with 
collagen only hydrogels than the scaffolds containing HyA hydrogels.  
 
Immunohistochemistry verified the presence of both collagen II and collagen I in 
the extracellular matrix. The prior confirms the presence of chondrocytes and 
new cartilage matrix formation, while the latter shows fibroblast invasion as well 
as dedifferentiated chondrocytes. Areas of detected collagen II correlated well 
with the areas of positive Safranin O staining, confirming the presence of 
cartilage-like matrix for both BMSC and chondrocyte-seeded constructs. 
(FIGURE 3.7) Collagen I was detected in areas of non-cartilaginous connective 
tissue and in some regions of weak Safranin O staining, such as the edges of the 
scaffolds and in pores with fibroblastic cells or where vascularization was 
observed.  (FIGURE 3.8) 
 
Positive Safranin O staining was found in all specimens, but more robust and 
intense staining was seen in scaffolds with composite 5% HyA/collagen 
hydrogels than with collagen I only hydrogels.  Histomorphometrical analysis of 
the Safranin O stained slides confirmed these observations (Figure 3.9a).  BMSC 
seeded in PCL scaffolds using 5% HyA composite hydrogels showed greater 
areas of chondrogenic differentiation compared to scaffolds with collagen I 
hydrogels.  The positively stained area for the BMSC seeded scaffolds was 
3.5±1% and 10±5% for collagen I and 5% HyA hydrogels, respectively.  For 
chondrocytes seeded in PCL scaffolds, the percentage of pore area stained 
positive with Safranin O for scaffolds seeded with composite 5% HyA hydrogels 
was 63±6.  The percentage of pore area stained positive with Safranin O for 
scaffolds seeded with collagen I only hydrogels was 29±4. Statistical analysis 
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showed that the chondrocytes cultured in composite 5% HyA/collagen I 
hydrogels had significantly greater areas of positive Safranin O staining.  
 
The average intensity of the Safranin O staining was converted to sGAG 
concentration using a calibration curve.  The intensity of the Safranin O stain 
correlates directly to the amount of sGAG present in the matrix.25  The average 
GAG concentration for BMSC seeded scaffolds was 3.2±0.3 and 3.6±0.2 µg/mm2 
for collagen and 5% HyA hydrogels, respectively (FIGURE 3.9b).  The average 
sGAG concentration for chondrocyte-seeded scaffolds with collagen I hydrogels 
was 7.1±2 µg/mm2.  The average sGAG concentration for the scaffolds with 5% 
HyA/collagen I hydrogels alone was 9.5±0.9 µg/mm2.  The results showed 
significantly greater amounts of sGAG in the extracellular matrix of the scaffolds 
with 5% HyA hydrogels for chondrocytes only. 
 
The extracellular matrix forming capability of fibroblast-like chondrocytes was 
also evaluated within composite 5% HyA and within collagen hydrogels.  These 
chondrocytes had been cultured on monolayer for 5 weeks and had been 
passaged six times.  After the long culture period, the cells had lost their round 
morphology and had become cuboidal and fibroblast-like in shape. Previous 
studies have shown that passaging chondrocytes and extended monolayer 
culture reduce the cells ability to produce collagen II and other cartilage 
proteoglycans. 24  Even when the cells are returned to a three-dimensional 
environment, the ability of the chondrocytes to ‘redifferentiate’ and regain the 
chondrocytic phenotype is still greatly reduced.  After the two week in vitro 
culture period and four week implantation, the fibroblastic chondrocytes with 
reduced chondrocytic capacities showed qualitatively greater areas of Safranin O 
staining with the 5% HyA hydrogels (FIGURE 3.10), while almost no Safranin O 
staining was observed within the scaffolds with collagen hydrogels. The 
presence of the HyA may help the fibroblastic chondrocytes redifferentiate back 
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into chondrocytes or help maintain their chondrocytic phenotype and aid in the 
formation of cartilage-like matrix. 
 
The results from the histomorphometric image analysis indicate that more 
chondrocytes are present in the 5% HyA hydrogel than the collagen I hydrogels. 
We conclude that HyA stimulates chondrogenic differentiation of BMSC, 
promotes proteoglycan synthesis of chondrocytes, and increases phenotype 




The aim of this study was to evaluate the effects of composite HyA/collagen I 
hydrogels on BMSC and chondrocyte activity in vitro and to analyze the 
feasibility of using HyA as a chondroconductive cell carrier for use with SFF 
scaffolds in vivo.  Currently, most clinical applications of hyaluronic acid are 
administered as interarticular injections, where the residence time of the HyA is 
limited to days.25  The incorporation of HyA into collagen I hydrogels may 
increase the lifetime in vivo and extend the timeframe of its chondroprotective 
properties. 
 
Hyaluronic acid, at low concentrations, modulates cell proliferation, matrix 
synthesis, and cellular condensation.  Our results are consistent with previous 
studies, where increases in sGAG production and cell proliferation were seen 
with the addition of HyA concentrations between 0.1 to 0.5 mg/mL.14,26  The 
HyA concentrations studied in these experiments increased aggregate formation, 
sGAG production and increased cell proliferation.  The increase in sGAG/DNA 
ratios in the BMSC seeded hydrogels that contained 5% HyA after one week of 
culture indicate the ability of HyA to initiate cellular condensation at a critical 
level that stimulates early chondrogenesis.  This effect is even more pronounced 
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in the two week data, which show the BMSC within the 5% HyA hydrogels 
cultured in basal media were able to differentiate into chondrocytes without the 
addition of exogenous growth factors.  The sGAG/DNA ratio of these hydrogels 
is comparable to the ratios found in chondrocytes that were cultured in the 
control hydrogels.  We believe that the HyA is able to induce chondrogenesis by 
helping the cells attain the critical condensation size required for differentiation. 
 
At a favorable concentration, an increased number of cells are able to bind to 
HyA that is in the environment to promote cell movement, proliferation, 
aggregation, degradation of HyA, and mediate the formation of pericellular 
matrices.27 Beyond this concentration; the aggregation effect is inhibited due to 
the saturation of cell receptors for HyA.28  This effect was seen with the cells in 
the 10% HyA hydrogels, where cellular aggregate formation was limited.  
Furthermore, at high concentrations of HyA, the individual HyA domains 
overlap and may form entanglements through self association and steric 
interactions.29,30  These steric interactions and hydrophobic patches may deter 
proteins and other molecules with large hydrodynamic sizes from diffusing 
through the composite HyA hydrogels.  This may explain some of the mixed 
results that were seen in the 10% HyA hydrogels, where the sGAG production 
and cellular metabolism may have been affected. 
 
The culture medium is also a contributing factor in cellular metabolism and 
matrix synthesis.  The BMSC were the most influenced by the defined 
chondrogenic medium, while the effects on chondrocytes were less implicit.  Our 
results show that the chondrogenic medium increased sGAG/DNA at both 
timepoints for hydrogels seeded with BMSC at all concentrations of HyA.  
Hydrogels seeded with chondrocytes containing collagen I and the 10% HyA 
hydrogel at one week, although mainly small differences were seen between the 
other composite HyA hydrogels cultured in basal and chondrogenic medium.  
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This difference may also be attributed to the steric inhibitions and entanglements 
of the HyA molecules preventing the proteins in the chondrogenic medium from 
diffusing into the hydrogels.  Due to the hydrophobic patches that are created by 
the HyA domain (FIGURE 3.11), molecules with larger hydrodynamic sizes will 
diffuse slower through the hydrogels.31  This indicates that the interactions of 
HyA molecules may be influencing nutrient diffusion into the hydrogels, 
particularly at the higher HyA concentrations.  Furthermore, contrary to our 
expectations, the increase in cell proliferation seen with cells cultured in 
chondrogenic medium was not accompanied by a proportionate increase in 
sGAG production.  This may explain the decrease of the sGAG/DNA ratio from 
week one to week two.  Further analysis of the quantitative gene expression and 
assessment of the collagen production of these cells may help clarify these results. 
 
The beneficial effects of the HyA are also seen after four weeks of in vivo 
implantation.  Larger areas of cartilage-like matrix and higher concentrations of 
sGAG show that the pre-culture step is important in attaining hyaline tissue in 
vivo.  The initial culture conditions are critical in determining the type of tissue 
that is formed.  The two week pre-culture period is essential in organizing the 
cells and helping them establish pericellular matrices and other extracellular 
support within the SFF scaffolds.32,33  The pre-culture period is also favorable for 
cellular retention. 34 , 35  The three-dimensional environment provided by the 
scaffold stimulates ECM production in chondrocytes and provides an 
environment that is conducive for chondrogenic differentiation of the BMSC.  
The addition of HyA to the collagen hydrogels significantly increased the quality 
of generated tissue.  The presence of HyA mediated the formation of pericellular 
matrices by the chondrocytes and helped them reestablish their niches within the 
SFF scaffolds.36  The chondrocytes cultured in collagen hydrogels would have 
required more time to restore chondrons and pericellular matrices. 37  
Furthermore, the presence of HyA in the hydrogels was able to increase the 
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production of cartilage-like extracellular matrix by passage 6 chondrocytes. 
(FIGURE 3.10)  Greater areas of Safranin O staining were seen within the 
scaffolds with the 5% HyA/collagen hydrogels compared to scaffolds with 
collagen only hydrogels. 
 
Overall, our results show that the addition of HyA to collagen I hydrogels 
created an environment that may be more conducive for BMSC differentiation, 
cellular proliferation and increased extracellular matrix production.  Both BMSC 
and chondrocytes are able to bind to HyA through surface receptors such as 
CD44 and RHAMM.38  The binding of the cells to HyA may not only increase 
cellular retention within the hydrogels, but also reduce morphological changes 
due to interactions with collagen I fibrils.5 The presence of HyA may also 
increase the number of attachment sites for chondroitin sulphate, keratan 
sulphate, and other sGAG.  The increases in sGAG retention within the 
hydrogels can be seen with the increase of sGAG measured in the composite gels 
with the DMMB assay.  The increase of sGAG is also seen in vivo, where the area 
of positive Safranin O staining and the intensity of the stain was significantly 
higher than in the collagen I hydrogels.  Furthermore, the increase of sGAG 
binding to HyA may enhance the compressive properties of the hydrogel by 




In conclusion, the beneficial effects of hyaluronic acid make it a good candidate 
substrate for use in cartilage tissue engineering applications, but there are limits 
to this effect depending on the concentration of HyA.  At high concentrations, 
the effects of steric inhibition, self association, and chain entanglement become 
important factors influencing nutrient diffusion and cellular metabolism.  Our 
results show that the addition of hyaluronic acid to collagen hydrogels is better 
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than collagen I alone for both BMSC and chondrocytes.  The most beneficial 
concentration studied in these experiments was a 5% HyA hydrogel, which was 
shown by the increased cellular condensation, cell proliferation, and sGAG 
content over all groups tested.  These composite HyA hydrogels are compatible 
with SFF scaffolds and helped to increase the areas of cartilage matrix formation 
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